Irritable Bowel Syndrome News

As any self-respecting American marijuana smoker can attest, the nation’s complicated relationship with the drug dates at least as far back as the Founding Fathers: Both George Washington and Thomas Jefferson were known to grow acres of hemp — marijuana’s far less-psychoactive cannabis cousin — on their Virginia plantations.

Two adults with weakened immune systems who received investigational fecal microbiota transplantations developed invasive infections caused by extended-spectrum beta-lactamase-producing Escherichia coli, according to an FDA press release.

The FDA announced today that it permits marketing of the first medical device to help reduce functional abdominal pain for patients 11 to 18 years of age with irritable bowel syndrome when combined with other therapies for the syndrome.

SAN DIEGO — Orally delivered fecal microbiota transplantation did not help reduce symptoms in patients with diarrhea-predominant irritable bowel syndrome whether or not they were pre-treated with antibiotics, according to data presented at Digestive Disease Week.

SAN DIEGO — Over the next four days, the gastroenterology community will convene in the San Diego Convention Center for Digestive Disease Week 2019, the specialty’s largest scientific conference.

Healio Gastroenterology and Liver Disease compiled a list of some of the top stories we posted in April.

It’s hard to imagine that an estimated 51,000 or more individuals will lose their lives to colorectal cancer in 2019. It’s hard to imagine because it is one of the few cancers that can be screened for, detected and prevented at an early stage so individuals do not have to suffer, and ultimately die, from this disease.

In the fall of 2016, I was selected to take part in the ACG-FDA fellowship where I was embedded with the Division of Gastroenterology and Inborn Errors Products in the Center for Drug Evaluation and Research at the FDA for one month.

Twenty years ago, when Mark Pimentel, MD, FRCP(C), released some of the first papers showing an impact on irritable bowel syndrome by eradication of bacterial overgrowth in the small intestine, he was met with disregard, disbelief and controversy.

PHILADELPHIA — The FODMAP diet may offer benefits for some patients with irritable bowel syndrome, but is not a fit for all patients, a speaker at the American College of Physicians Internal Medicine Meeting suggested.